Pivotal bioVenture Partners Investment Advisor LLC — 13F Holdings & Portfolio
CIK 1844645 · latest 13F-HR filed 2026-11-13
Pivotal bioVenture Partners Investment Advisor LLC manages $251.8M in 13F-reported U.S. long-equity assets across 14 reported positions as of its 2026-09-30 13F-HR filing. Its largest disclosed positions are PCVX (32.22%), ARQT (10.58%), TRVI (9.91%). Quarter over quarter (versus its 2026-06-30 filing) the fund opened 2 new positions and exited 1; 1 existing position rose in reported value and 9 fell.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
Long-equity book
Distinct positions
Filed 2026-11-13
vs 2026-06-30
Portfolio charts
Latest quarter's book, what changed, and how the portfolio has evolved across filings.
Portfolio map
Q3 26Box size = position value; colour = change in share count vs the prior quarter (green added, red trimmed, blue new). Rows split across managers or share classes are combined. Click a box for the stock.
Sector mix
% of 13F valueSectors from each company's SIC code; funds and ETFs grouped separately.
Biggest buys and sells
Q2 26 → Q3 26Estimated from the change in shares held × the quarter-end price, so price moves alone don't count as buying. New and exited positions are included.
13F assets and positions
5 quartersTotal reported 13F value (bars) and number of positions (line) each quarter. Value changes include market moves.
Top positions over time
reported valueThe eight largest current positions, valued at each quarter end.
Concentration
top 10 = 91.1%Cumulative share of the portfolio held in the largest N positions.
As of the firm’s regulatory filing dated Jun 25, 2026.
SUITE 200
SAN FRANCISCO, CA 94107
| Name | Title / Status | Ownership | Type |
|---|---|---|---|
| BISGAARD, PETER, TUXEN Control | MANAGING DIRECTOR since Jun 2022 | Less than 5% | Individual |
| HOPFNER, ROBERT, LORNE Control | MANAGING DIRECTOR since Dec 2017 | Less than 5% | Individual |
| PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD Control | GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P. since Dec 2016 | 75% or more | Foreign Entity |
| PIVOTAL PARTNERS LTD Control | OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD since Dec 2016 | 75% or more | Foreign Entity |
| PIVOTAL PARTNERS LTD Control | MEMBER since Oct 2025 | 75% or more | Foreign Entity |
| TRAVERS, MICHAEL, LAWRENCE Control | US CHIEF OPERATING OFFICER AND GENERAL COUNSEL since Aug 2022 | Less than 5% | Individual |
| TSE, BRIAN, KIN KWOK | OFFICER since Mar 2018 | Less than 5% | Individual |
| CHEN'S GROUP HOLDINGS LIMITED Control Indirect owner via NAN FUNG INTERNATIONAL HOLDINGS LIMITED | SHAREHOLDER since Aug 2014 | 75% or more | Foreign Entity |
| CHEN'S GROUP INTERNATIONAL LIMITED Control Indirect owner via CHEN'S GROUP HOLDINGS LIMITED | SHAREHOLDER since Aug 2011 | 75% or more | Foreign Entity |
| NAN FUNG GROUP HOLDINGS LIMITED Control Indirect owner via NF INVESTMENT HOLDINGS LIMITED | SHAREHOLDER since Sep 1999 | 75% or more | Foreign Entity |
| NAN FUNG INTERNATIONAL HOLDINGS LIMITED Control Indirect owner via NAN FUNG GROUP HOLDINGS LIMITED | SHAREHOLDER since Aug 2011 | 75% or more | Foreign Entity |
| NAN FUNG LIFE SCIENCES HOLDINGS LIMITED Control Indirect owner via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED | SHAREHOLDER since Mar 2016 | 75% or more | Foreign Entity |
| NF INVESTMENT HOLDINGS LIMITED Control Indirect owner via NAN FUNG LIFE SCIENCES HOLDINGS LIMITED | SHAREHOLDER since Nov 2012 | 75% or more | Foreign Entity |
| PIVOTAL LIFE SCIENCES HOLDINGS LIMITED Control Indirect owner via PIVOTAL PARTNERS LTD | SHAREHOLDER since Nov 2016 | 75% or more | Foreign Entity |
| PIVOTAL PARTNERS LTD Control Indirect owner via PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD | SHAREHOLDER since Dec 2016 | 75% or more | Foreign Entity |
Ownership & leadership changes · 8 filings with changes since Mar 16, 2017
From the firm’s regulatory filings, newest first. Dates are filing dates: a filing that no longer lists someone does not say when they left.
- No longer listedNAN FUNG SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person · listed since Mar 2016
- No longer listedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG SCIENCES HOLDINGS LIMITED · control person · listed since Nov 2012
- No longer listedPIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · MEMBER · 75% or more · control person · listed since Dec 2016
- No longer listedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · control person · listed since Dec 2016
- AddedNAN FUNG LIFE SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person
- AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES HOLDINGS LIMITED · control person
- ChangedHOPFNER, ROBERT, LORNE · title OFFICER → MANAGING DIRECTOR
- ChangedPIVOTAL PARTNERS LTD · title OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P., LTD. → MEMBER / OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P. LTD
- ChangedTRAVERS, MICHAEL, LAWRENCE · title CORPORATE COUNSEL AND CHIEF OPERATING OFFICER → US CHIEF OPERATING OFFICER AND GENERAL COUNSEL
- ChangedPIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · title GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I, G.P., L.P. → GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.
- ChangedPIVOTAL PARTNERS LTD · title OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II, G.P., LTD. → OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II G.P., LTD.
- AddedPIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · GENERAL PARTNER OF PIVOTAL BIOVENTURE PARTNERS FUND I, G.P., L.P. · 75% or more · control person
- AddedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS FUND I U.G.P. LTD · control person
- AddedPIVOTAL PARTNERS LTD · OWNER OF PIVOTAL BIOVENTURE PARTNERS FUND II, G.P., LTD. · 75% or more · control person
- AddedTRAVERS, MICHAEL, LAWRENCE · CORPORATE COUNSEL AND CHIEF OPERATING OFFICER · Less than 5% · control person
- No longer listedPreston, Heather · OFFICER · Less than 5% · control person · listed since Jul 2018
- AddedBISGAARD, PETER, TUXEN · MANAGING DIRECTOR · Less than 5% · control person
- No longer listedNAN FUNG LIFE SCIENCES LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD. · control person · listed since Nov 2016
- No longer listedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via WISDOM SKY INVESTMENTS LIMITED · control person · listed since Nov 2012
- No longer listedWISDOM SKY INVESTMENTS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES LIMITED · control person · listed since Mar 2016
- AddedNAN FUNG SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL LIFE SCIENCES HOLDINGS LIMITED · control person
- AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG SCIENCES HOLDINGS LIMITED · control person
- AddedPIVOTAL LIFE SCIENCES HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD · control person
- AddedCHEN'S GROUP HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG INTERNATIONAL HOLDINGS LIMITED · control person
- AddedCHEN'S GROUP INTERNATIONAL LIMITED · SHAREHOLDER · 75% or more · indirect via CHEN'S GROUP HOLDINGS LIMITED · control person
- AddedNAN FUNG GROUP HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NF INVESTMENT HOLDINGS LIMITED · control person
- AddedNAN FUNG INTERNATIONAL HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG GROUP HOLDINGS LIMITED · control person
- AddedNAN FUNG LIFE SCIENCES LIMITED · SHAREHOLDER · 75% or more · indirect via PIVOTAL PARTNERS LTD. · control person
- AddedNF INVESTMENT HOLDINGS LIMITED · SHAREHOLDER · 75% or more · indirect via WISDOM SKY INVESTMENTS LIMITED · control person
- AddedWISDOM SKY INVESTMENTS LIMITED · SHAREHOLDER · 75% or more · indirect via NAN FUNG LIFE SCIENCES LIMITED · control person
- ChangedPIVOTAL PARTNERS LTD · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD: now a control person
- AddedPreston, Heather · OFFICER · Less than 5% · control person
- AddedTSE, BRIAN, KIN KWOK · OFFICER · Less than 5%
- No longer listedSaxton, Tracy, M · OFFICER · Less than 5% · control person · listed since Dec 2016
- AddedHOPFNER, ROBERT, LORNE · OFFICER · Less than 5% · control person
- ListedPIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD · MEMBER · 75% or more · control person
- ListedPIVOTAL PARTNERS LTD · SHAREHOLDER · 75% or more · indirect via PIVOTAL BIOVENTURE PARTNERS MANAGEMENT LTD
- ListedSaxton, Tracy, M · OFFICER · Less than 5% · control person
Quarter-over-quarter changes
Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.
Top Trims
- MAPLIGHT THERAPEUTICS INC-$15.7M -71.6%
- BIOAGE LABS INC-$11.4M -71.1%
- EVOMMUNE INC-$9.7M -37.8%
- TREVI THERAPEUTICS INC-$7.5M -23.2%
- AVALYN PHARMACEUTICALS INC-$7.1M -22.4%
Pivotal bioVenture Partners Investment Advisor LLC Holdings (2026-09-30)
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | VAXCYTE INC | PCVX | 92243G108 | $81.1M | 32.22% | 1,425,470 | SH |
| 2 | ARCUTIS BIOTHERAPEUTICS INC | ARQT | 03969K108 | $26.6M | 10.58% | 1,008,174 | SH |
| 3 | TREVI THERAPEUTICS INC | TRVI | 89532M101 | $25.0M | 9.91% | 1,742,672 | SH |
| 4 | AVALYN PHARMACEUTICALS INC | AVLN | 05348Y105 | $24.7M | 9.81% | 866,792 | SH |
| 5 | EVOMMUNE INC | EVMN | 30054Y107 | $15.9M | 6.32% | 1,926,943 | SH |
| 6 | IMMUNOME INC | IMNM | 45257U108 | $15.8M | 6.26% | 732,512 | SH |
| 7 | OCULIS HOLDING AG | OCS | H5870P102 | $15.5M | 6.15% | 1,658,907 | SH |
| 8 | OBSIDIAN THERAPEUTICS INC | OBX | 67448A106 | $11.8M | 4.69% | 860,343 | SH |
| 9 | AVALO THERAPEUTICS INC | AVTX | 05338F306 | $6.7M | 2.64% | 434,033 | SH |
| 10 | BRAVEHEART BIO INC | BRVE | 10567X101 | $6.4M | 2.55% | 317,351 | SH |
| 11 | ZENAS BIOPHARMA INC | ZBIO | 98937L105 | $6.3M | 2.50% | 233,176 | SH |
| 12 | MAPLIGHT THERAPEUTICS INC | MPLT | 56565P103 | $6.2M | 2.47% | 611,446 | SH |
| 13 | RALLYBIO CORP | RLYB | 75120L209 | $5.2M | 2.05% | 300,579 | SH |
| 14 | BIOAGE LABS INC | BIOA | 09077V100 | $4.6M | 1.84% | 653,374 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-13 | $251.8M | 14 | 0001012975-26-001045 |
| 2026-06-30 | 2026-08-13 | $307.8M | 13 | 0001012975-26-000759 |
| 2026-03-31 | 2026-05-14 | $279.8M | 13 | 0001012975-26-000421 |
| 2025-12-31 | 2026-02-13 | $258.7M | 12 | 0001012975-26-000133 |
| 2025-09-30 | 2025-11-13 | $173.0M | 10 | 0001012975-25-000748 |
SAN FRANCISCO, CA 94107